Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price on Feb 4, 2025

Avid Bioservices Revenue

Avid Bioservices had revenue of $33.48M in the quarter ending October 31, 2024, with 31.84% growth. This brings the company's revenue in the last twelve months to $150.45M, up 6.75% year-over-year. In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M, down -6.27%.

Revenue (ttm)
$150.45M
Revenue Growth
+6.75%
P/S Ratio
5.28
Revenue / Employee
$405,512
Employees
371
Market Cap
798.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 2024139.91M-9.36M-6.27%
Apr 30, 2023149.27M29.67M24.81%
Apr 30, 2022119.60M23.73M24.75%
Apr 30, 202195.87M36.17M60.58%
Apr 30, 202059.70M6.10M11.38%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro